Back
Blueprint Medicines Stock Predictions
![](/images/offers/ims/large/offer17.jpg)
A Silent Invasion of America
Click here to see what you can do to make sure you're not left behind.
Sell
46
BPMC
Blueprint Medicines
Last Price:
111.72
Seasonality Move:
10.58%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer19.jpg)
Watch this free video on trading overnight options
Get the free overnight options training here.Blueprint Medicines Stock Forecast
- Over the next 52 weeks, Blueprint Medicines has on average historically risen by 27.8% based on the past 9 years of stock performance.
- Blueprint Medicines has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Blueprint Medicines Stock Undervalued?
The current Blueprint Medicines [BPMC] share price is $111.70. The Score for BPMC is 46, which is 8% below its historic median score of 50, and infers higher risk than normal. - BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Blueprint Medicines Stock Go Up Next Year?
- Over the next 52 weeks, Blueprint Medicines has on average historically risen by 27.8% based on the past 9 years of stock performance.
Blueprint Medicines Stock Rating
Sell
46
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines overpriced?
- Blueprint Medicines has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Blueprint Medicines Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
blueprintmedicines.com
52-Week Data
52-Week High:
111.99
52-Week Low:
43.89
Prediction Charts
Market Cap:
6.99B
Price in USD:
111.70
Volume:
343.02K
Beta:
0.88
Technical Analysis
SMA50:
104.24
SMA100:
96.96
SMA200:
82.56
52-Wk Change:
81.27%
Stock Predictions
-
Is Blueprint Medicines stock public?
Yes, Blueprint Medicines is a publicly traded company. -
What is the Blueprint Medicines stock quote today?
The Blueprint Medicines stock price is 111.70 USD today. -
How to buy Blueprint Medicines stock online?
You can buy Blueprint Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jun-14 | 104.44 | 105.55 | 106.86 | 103.49 |
Jun-17 | 105.04 | 103.87 | 107.60 | 102.87 |
Jun-18 | 103.85 | 106.71 | 107.12 | 102.55 |
Jun-20 | 105.81 | 105.21 | 107.20 | 103.15 |
Jun-21 | 106.03 | 104.23 | 106.51 | 102.37 |
Jun-24 | 104.30 | 106.00 | 106.76 | 101.78 |
Jun-25 | 105.76 | 106.51 | 110.57 | 104.72 |
Jun-26 | 106.08 | 103.92 | 106.50 | 103.59 |
Jun-27 | 105.02 | 108.52 | 108.92 | 103.02 |
Jun-28 | 109.40 | 107.88 | 111.42 | 105.52 |
Jul-1 | 107.68 | 109.18 | 110.00 | 107.08 |
Jul-2 | 108.93 | 110.36 | 110.46 | 107.46 |
Jul-3 | 110.43 | 109.03 | 111.89 | 108.82 |
Jul-5 | 108.47 | 111.70 | 111.99 | 108.33 |
Blueprint Medicines Earnings
Blueprint Medicines Earnings Report: Per Share Blueprint Medicines Earnings Q1 Q2 Q3 and Q4 last year and next year.
Blueprint Medicines Forecast Revenue Growth
Blueprint Medicines Stock Analysis: Historical quarterly revenues per share for Blueprint Medicines and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $1.17 per share, an increase next quarter of $0.33 per share, an increase this year of $5.90 per share, and an increase next year of $0.62 per share.
* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.